References
- 1. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952; 40: 423-41.10.1016/S0022-3476(52)80205-7
- 2. Tanner JM, Goldstein H, Whitehouse RH. Standards for children’s heights at age 2-9 years allowing for height of parents. Arch Dis Child. 1970; 45:755-62.10.1136/adc.45.244.755
- 3. Bridges NA, Christopher JA, Hindmarsh PC, Brook CGD. Sexual precocity: sex incidence and aetiology. Arch Dis Child. 1994; 70:116-8.
- 4. Wacharasindhu S, Likitmaskul S, Punnakanta L, Augsusingha K, Tuchinda C, Thanakitcharu K. Precocious puberty. Siriraj Hosp Gaz. 1994; 46:440-6.
- 5. Cesario SK, Hughes LA. Precocious puberty: a comprehensive review of literature. JOGNN 2007; 36: 263-74.10.1111/j.1552-6909.2007.00145.x
- 6. Bar A, Linder B, Sobel EH, Saenger P, DiMartino- Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr. 1995; 126:955-8.
- 7. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of prediction by the Bayley-Pinneau method. Horm Res. 1997; 47:54-61.
- 8. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, et al. Final height after long-term treatment with triptorelin slow-release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endocrinol Metab. 1999; 84:1973-8.10.1210/jcem.84.6.5647
- 9. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, et al. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol. 1999; 141:140-4.
- 10. Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GBJ. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab. 2001; 86:4711-6.10.1210/jcem.86.10.7915
- 11. Kletter GM, Kelch RP. Clinical review 60: effects of gonadotropin-releasing hormone analogue therapy on adult stature in precocious puberty. J Clin Endocrinol Metab. 1994; 79:331-4.
- 12. Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Corrias A, De Luca F, et al. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. Acta Paediatr. 1994; 83:1052-6.10.1111/j.1651-2227.1994.tb12984.x
- 13. Cassio A, Cacciari E, Balsamo A, Bal M, Tassinari D. Randomized trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years. Arch Dis Child. 1999; 81:329-32.10.1136/adc.81.4.329
- 14. Lazar L, Kauli R, Pertzelan A, Phillip M. Gonadotropinsuppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab. 2002; 87:2090-4.10.1210/jcem.87.5.8481
- 15. Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, Chaussain JL, et al. Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metab. 1999; 84:3575-8.10.1210/jcem.84.10.6032
- 16. Biro FM, McMahon RP, Striegel-Moore R, Crawford PB. Obarzanek E. Morrison JA, et al. Impact of timing of pubertal maturation on growth in black and white female adoleacents: The National Heart, Lung and Blood Institute Growth and Health Study. J Pediatr. 2001; 138:636-43.
- 17. Rogol AD. Early menarche and adult height: reprise of the hare and the tortoise? J Pediatr. 2001; 138:617-8.
- 18. Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Sahakitrungrueng T. Pubertal growth in normal Thai children: a longitudinal study. Asian Biomed. 2010; 4:793-5.